Cleared Traditional

K822308 - VANCOMYCIN FLUORESCENT IMMUNOASSAY

K822308 is the FDA 510(k) clearance for VANCOMYCIN FLUORESCENT IMMUNOASSAY by American Diagnostic Corp.. It is a Class 2 Toxicology device (product code LEH) cleared through the Traditional 510(k) pathway after a 13-day FDA review.

K822308 · American Diagnostic Corp. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1982
Decision
13d
Days
Class 2
Risk

K822308 is an FDA 510(k) clearance for the VANCOMYCIN FLUORESCENT IMMUNOASSAY. Classified as Radioimmunoassay, Vancomycin (product code LEH), Class II - Special Controls.

Submitted by American Diagnostic Corp. (Mchenry, US). The FDA issued a Cleared decision on August 16, 1982 after a review of 13 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3950 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Diagnostic Corp. devices

Submission Details

510(k) Number K822308 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 03, 1982
Decision Date August 16, 1982
Days to Decision 13 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 87d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LEH Radioimmunoassay, Vancomycin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3950
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LEH Radioimmunoassay, Vancomycin

All 20
Devices cleared under the same product code (LEH) and FDA review panel - the closest regulatory comparables to K822308.
ACA VANCOMYCIN (VANC) METHOD
K892900 · E.I. Dupont DE Nemours & Co., Inc. · May 1989
EMIT VANCOMYCIN ASSAY
K881040 · Syva Co. · Apr 1988
STRATUS VANCOMYCIN FLUOROMETRIC ENZYME IMMUNOASSAY
K874438 · Baxter Healthcare Corp · Jan 1988
TDX TM STREPTOMYCIN
K821136 · Abbott Laboratories · May 1982
TDX VANCOMYCIN
K813218 · Abbott Laboratories · Dec 1981